Gilead Sciences to Present at the UBS Global Healthcare Conference on Monday, May 23
Webcast Available Through Gilead Corporate Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the UBS Global
Healthcare Conference in New York.
Norbert W. Bischofberger, Gilead’s Executive Vice President, R&D and Chief Scientific Officer, will provide an overview of
the company at the conference on Monday, May 23 at 9:30 a.m. Eastern Time.
The live webcast can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the
presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be
available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or
1-650-574-3000.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations
View source version on businesswire.com: http://www.businesswire.com/news/home/20160520005701/en/